Welcome
RVMC is dedicated to establishing regional vaccine manufacturing and supply chain networks to improve vaccine equity and health security for all.
Learn more
The Context
The COVID-19 pandemic highlighted stark disparities in vaccine access, sparking efforts to rethink how and where vaccines are made.
Countries rightfully want to have greater health security and control over vaccine manufacturing within their borders. However, consolidating this approach at the regional level is more likely to achieve the necessary scale of demand, investment, and capability to maintain viable and sustainable vaccine production.
Regionalization of manufacturing represents a shift in the current global vaccine system: a shift that is already underway. With equity and health security at the core of their thinking, regions are now taking greater control over the production and supply of vaccines to meet their needs.
RVMC is focused on accelerating this transformation, supporting initiatives to ensure that regionalized vaccine manufacturing is economically sustainable and contributes to a growing global demand for vaccines.
3
The number of vaccine manufacturers across Africa, ASEAN, and LAC that produce 5 or more vaccines and have scaled their operations
10%
The share of combined vaccine demand across Africa, LAC, and ASEAN met by manufacturers within those regions.
5 years
The point at which the economic benefits of regionalized vaccine manufacturing can exceed the costs
Latest News
What is RVMC
In 2022, the World Economic Forum (WEF), the US National Academies of Medicine (NAM), and the Coalition of Epidemic Preparedness Innovations (CEPI) joined forces to launch RVMC, with the backing of a diverse coalition of partners. After a successful incubation period at the World Economic Forum, the RVMC Secretariat is now hosted by CEPI.
Our vision is a world where vaccine equity and health security are created for countries in all regions of the world.
We aim to achieve this vision through the establishment of regional vaccine manufacturing and supply chain networks capable of producing vaccines for routine use in a sustainable manner, with readiness for outbreak manufacturing.
Advocate
We make the case for fit-for-purpose regionalized vaccine manufacturing, helping both keep it a sustained priority and translate commitments into action.
Align
We facilitate discussion within and between regions and stakeholders, helping define shared RVM priorities and coordinate complementary action.
Advise
We provide independent, trusted advice and evidence to support sustainable vaccine manufacturing pathways across regional ecosystems.
Account
We observe and report on progress towards RVM, helping partners understand gaps, assess performance, and course-correct.
Who do we work with?
Regional Bodies
We support regional bodies with the political mandate to enhance vaccine manufacturing capabilities, aligning with their strategic goals.
National Governments
We advise national governments on their vaccine manufacturing plans, promoting coordination with like-minded countries and regional strategies.
Industry
We collaborate with industry partners to develop a comprehensive understanding of the landscape, identifying opportunities that align with regional strategies.
Funders
We provide guidance to funders on viable projects that align with regional vaccine manufacturing strategies.
International Organizations/Agencies
We work with international organizations to build consensus on the global vision for regionalized manufacturing and identify opportunities for collaborative partnerships.
Our Vision
In April 2025, we launched RVMC’s Vision for 2040, shaped by consultations with dozens of experts and policymakers worldwide. It identifies three priorities for building sustainable regionalized vaccine manufacturing: stronger political action, more predictable demand, and stronger, more harmonised regulatory systems.